Skip to main content
Study evaluates PET/CT-guided chemoradiotherapy in NSCLC

Researchers found patients with stage III non-small cell lung cancer who received FDG-PET/CT-guided concurrent chemoradiotherapy with training and quality control support benefited from increased treatment accuracy. The findings were published in the European Journal of Nuclear Medicine and Molecular Imaging.

Full Story: